Esam Baryun, MD
Cardiovascular Disease · Huntington, WVNPI 1962504829
Payments from drug & device makers
Across 771 payments — averaging $143.55 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$63K
- Medtronic$15K
- Abbott$12K
- Biosense Webster, Inc.$10K
- ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$4K
- Medical Device Business Services, Inc.$2K
- plus $5K from 29 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 139 | $63,052 |
| Medtronic(2 entities) | 180 | $14,692 |
| Abbott | 127 | $11,783 |
| Biosense Webster, Inc. | 18 | $9,557 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 97 | $3,938 |
| Medical Device Business Services, Inc. | 6 | $2,480 |
| Atricure, Inc. | 11 | $1,704 |
| Pfizer | 39 | $496 |
| Novartis | 25 | $430 |
| Philips North America LLC | 6 | $308 |
| Johnson & Johnson | 25 | $300 |
| Impulse Dynamics (USA) Inc. | 2 | $262 |
| Cook Medical LLC | 14 | $252 |
| E.r. Squibb & Sons, L.L.C. | 21 | $196 |
| Chiesi USA, Inc. | 9 | $145 |
| Inspire Medical Systems, Inc. | 1 | $138 |
| Boehringer Ingelheim | 8 | $120 |
| Amgen | 9 | $113 |
| Davol Inc. | 2 | $101 |
| Paratek Pharmaceuticals, Inc. | 5 | $91 |
| AstraZeneca | 6 | $83 |
| Kestra Medical Technology Services, Inc. | 2 | $81 |
| Cvrx, Inc. | 2 | $47 |
| Lundbeck LLC | 3 | $47 |
| Shield Therapeutics Inc | 2 | $45 |
| Lilly USA, LLC | 2 | $38 |
| Angiodynamics, Inc. | 1 | $32 |
| Otsuka America Pharmaceutical, Inc. | 2 | $30 |
| Cardiva Medical, Inc. | 1 | $21 |
| Sanofi-aventis U.S. LLC | 1 | $20 |
| Merck | 1 | $20 |
| Alnylam Pharmaceuticals Inc. | 1 | $16 |
| Elutia, Inc. | 1 | $15 |
| Biotronik Inc. | 1 | $15 |
| Gilead | 1 | $12 |
How this compares
$110,678 in reported general payments places this provider in the 90th percentile of 100 cardiovascular disease providers in West Virginia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other cardiovascular disease in Huntington
- Kofi OseiHuntington$87K
- Ellen ThompsonHuntington$56K
- Rameez SayyedHuntington$21K
- Jason MaderHuntington$13K
- Mark StudenyHuntington$8K
- Samian SulaimanHuntington$7K
- Amrit ThakurHuntington$5K
- Robert TouchonHuntington$4K
- Mehiar El-HamdaniHuntington$4K
- Scott MillerCharleston$2.5M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.